🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, Phase I, dose-escalation study to determine the reco...
Status
Completed
Location
Moores Cancer Center at UC San Diego /ID# 157374
Start Date
2016-12-14
Trial ID
NCT03000257
Treatments Being Tested
This is a Japanese, multicenter, open-label, dose-escalation study. This is...
Status
Completed
Location
National Cancer Ctr Hosp East /ID# 161432
Start Date
2017-04-28
Trial ID
NCT03086239
Treatments Being Tested
Study to evaluate the effect of rovalpituzumab tesirine on cardiac ventricu...
Status
Completed
Location
University of California Los Angeles
Start Date
2016-09
Trial ID
NCT02874664
Treatments Being Tested
A single-arm, open-label study to assess the overall safety of rovalpituzum...
Status
Withdrawn
Location
Ironwood Cancer & Res Ctr /ID# 171335
Start Date
2018-03-15
Trial ID
NCT03334487
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of rovalpitu...
Status
Terminated
Location
Ucsd /Id# 161030
Start Date
2017-03-30
Trial ID
NCT03026166
Treatments Being Tested
The purpose of this study is to determine the efficacy of rovalpituzumab te...
Status
Completed
Location
Multiple Locations
Start Date
2016-01-25
Trial ID
NCT02674568
Treatments Being Tested
This is a Phase 3, randomized, double-blind, placebo-controlled, multinatio...
Status
Terminated
Location
Clearview Cancer Institute /ID# 156699
Start Date
2017-02-07
Trial ID
NCT03033511
The purpose of the study is to test the effect of rovalpituzumab tesirine i...
Status
Terminated
Location
University of Colorado
Start Date
2016-10
Trial ID
NCT02819999
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Terminated
Location
Banner MD Anderson Cancer Ctr /ID# 155424
Start Date
2016-09-23
Trial ID
NCT02709889
Treatments Being Tested
The purpose of this long-term, extension study is to provide ongoing safety...
Status
Completed
Location
Arizona Oncology Associates, PC-HOPE (Rudasill) /ID# 204818
Start Date
2018-09-10
Trial ID
NCT03543358
Treatments Being Tested